瑞鑫國際集團(00724.HK)中期收入約1.24億港元 同比減少約25.5% 明日復牌
格隆匯9月29日丨瑞鑫國際集團(00724.HK)公吿,截至2022年6月30日止六個月,公司收入約1.24億港元,同比減少約25.5%。呈報期間虧損由相關期間約2380萬港元增加至約2540萬港元。
呈報期間虧損增加乃主要由於電子產品業務的營運虧損增加及可換股票據的推算利息支出增加所致。呈報期間的電子產品業務營運虧損增加乃主要由於在全球通脹憂慮加劇的情況下以及一些大型消費品製造商因手頭庫存不斷增加而暫停某些採購訂單,集團電子部件的訂單量縮減,導致收入減少。
公司已向聯交所申請公司股份自2022年9月30日上午九時正起於聯交所恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.